AI Article Synopsis
- The article DOI: 10.3389/fimmu.2024.1345473 was identified as needing correction.
- The correction aims to clarify or rectify specific information previously published in the article.
- This adjustment enhances the accuracy and integrity of the research presented in the original publication.
Article Abstract
[This corrects the article DOI: 10.3389/fimmu.2024.1345473.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11222687 | PMC |
| http://dx.doi.org/10.3389/fimmu.2024.1441999 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum to "Increasing the antitumor efficacy of doxorubicin liposomes with coupling an anti-EGFR affibody in EGFR-expressing tumor models" [Int. J. Pharm. 586 (2020) 119541].
Int J Pharm
January 2025
Laboratory of Drug Discovery and Design, School of Pharmacy, Liaocheng University, Liaocheng, Shandong 252000, PR China. Electronic address:
Corrigendum to "Mapping the genetic architecture of idiopathic pulmonary fibrosis: Meta-analysis and epidemiological evidence of case-control studies" [Gene 895 (2024) 147993].
Gene
January 2025
Academy of Scientific and Innovative Research (AcSIR), Ghaziabad-201002, India; Genomics and Molecular Medicine Unit, CSIR-Institute of Genomics and Integrative Biology (IGIB), New Delhi, India. Electronic address:
Corrigendum: Dynamic eye avoidance patterns in the high autistic traits group: an eye-tracking study.
Front Psychiatry
December 2024
Academy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, China.
[This corrects the article DOI: 10.3389/fpsyt.2023.
View Article and Find Full Text PDFCorrigendum to "Preventing severe hypoglycemia in adults with type 2 diabetes (PHT2): Design, delivery and evaluation framework for a randomized controlled trial" [Contemp Clin Trials 2024 Apr:139:107456, pgs 1-11].
Contemp Clin Trials
January 2025
Kaiser Permanente Washington Health Research Institute, 1730 Minor Ave, Seattle, WA 98101, USA.
Retraction notice to "Corrigendum to 'Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer' [International Journal of Biological Macromolecules 248 (2023) 125782]".
Int J Biol Macromol
January 2025
Institute of Biomedical Sciences, College of Medicine, National Sun Yat-sen University, Kaohsiung 80424, Taiwan; Department of Mechanical and Electro-Mechanical Engineering, National Sun Yat-sen University, Kaohsiung 80424, Taiwan.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!